Heng S. Li
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Efficacy and safety of antibody-drug conjugates in EGFR-mutant non-small cell lung cancer after tyrosine kinase inhibitor resistance: a systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: March 17, 2026
Progress in perioperative immunotherapy for lung cancer and analysis of therapy (Review).
Journal: Oncology letters
Published: June 05, 2025
HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.
Journal: Journal of translational medicine
Published: February 24, 2023
Prognostic value of lactate dehydrogenase in non-small cell lung cancer patients with brain metastases: a retrospective cohort study.
Journal: Journal of thoracic disease
Published: October 09, 2022
Erratum: Econazole nitrate reversed the resistance of breast cancer cells to Adriamycin through inhibiting the PI3K/AKT signaling pathway.
Journal: American journal of cancer research
Published: April 18, 2022
Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients.
Journal: Frontiers in oncology
Published: October 26, 2020
Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: September 29, 2020
CAR-T Immunotherapy and Non-small Cell Lung Cancer: Bottleneck and Dawn
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: August 19, 2020
Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: May 26, 2020
Last Updated: 09/26/2026